ARO-ATXN2

N/A

Report date: 2026/02/07 20:00:33
NME

Base Information

Drug NameARO-ATXN2
Drug Alias NameARO-ATXN2
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionAtaxin-2 expression inhibitors
TargetsAtaxin-2
Therapy Area/IndicationsSpinocerebellar Ataxias
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaTaiwanNew Zealand +[8] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesArrowhead Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesSarepta Therapeutics IncArrowhead Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsSpinocerebellar Ataxias
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A